Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer

Jörg Kleeff, Toshiyuki Ishiwata, Helmut Friess, Markus W. Búchler, Murray Korc

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Activins and inhibins belong to the transforming growth factor-β (TGF- β) superfamily of multifunctional cytokines that bind to transmembrane receptors with serine/threonine kinase activity. In this study, we characterized the levels of expression of 3 activin/inhibin subunits (βA, βB, α), and 2 type I and type II activin receptors (actRI/Ib, actRII/IIb) in pancreatic cancer cell lines and in human pancreatic tissues. In addition, we assessed the growth responsiveness to activin A in these cell lines. All 6 cell lines (ASPC-I, CAPAN-I, COLO-3S7, MIA-PaCa-2, PANC-I and T3M4) expressed the activin/inhibin βA subunit, whereas expression levels of the activin/inhibin βB and α subunits were undetectable. Furthermore, actRI, actRII and actRIIb were expressed in all cell lines and actRib mRNA was evident in ASPC-I, CAPAN-I, COLO357 and PANC-I cells. CAPAN-I and COLO-357 cells were growth-stimulated by activin A in the presence of 10% serum, whereas the other cell lines were resistant to activin A. In contrast, in serum-free medium activin A inhibited the growth of CAPAN-I, COLO-357 and MIA-PaCa-2 cells. Pancreatic cancer samples markedly over-expressed the activin/inhibin βA subunit, whereas the βB subunit was only moderately increased in comparison to normal pancreatic samples. Pancreatic cancer tissues also markedly over-expressed actRI, actRib and actRII. By in situ hybridization, activin/inhibin βA, actRI, actRIb and actRII were strongly expressed in diffuse infiltrative and duct-like cancer cells. Both the ligand and its receptors were often co-expressed in these cells. Together, our findings suggest that activin A may participate in autocrine activation of pancreatic cancer cells in vivo.

Original languageEnglish (US)
Pages (from-to)860-868
Number of pages9
JournalInternational Journal of Cancer
Volume77
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Activins
Inhibins
Pancreatic Neoplasms
Cell Line
Type I Activin Receptors
Type II Activin Receptors
Growth
Protein-Serine-Threonine Kinases
Serum-Free Culture Media
Transforming Growth Factors
In Situ Hybridization
activin A
Cytokines
Ligands
Messenger RNA
Serum
inhibin A
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer. / Kleeff, Jörg; Ishiwata, Toshiyuki; Friess, Helmut; Búchler, Markus W.; Korc, Murray.

In: International Journal of Cancer, Vol. 77, No. 6, 1998, p. 860-868.

Research output: Contribution to journalArticle

Kleeff, Jörg ; Ishiwata, Toshiyuki ; Friess, Helmut ; Búchler, Markus W. ; Korc, Murray. / Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer. In: International Journal of Cancer. 1998 ; Vol. 77, No. 6. pp. 860-868.
@article{ecbcf5daa9cc4fe39aed815db1229687,
title = "Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer",
abstract = "Activins and inhibins belong to the transforming growth factor-β (TGF- β) superfamily of multifunctional cytokines that bind to transmembrane receptors with serine/threonine kinase activity. In this study, we characterized the levels of expression of 3 activin/inhibin subunits (βA, βB, α), and 2 type I and type II activin receptors (actRI/Ib, actRII/IIb) in pancreatic cancer cell lines and in human pancreatic tissues. In addition, we assessed the growth responsiveness to activin A in these cell lines. All 6 cell lines (ASPC-I, CAPAN-I, COLO-3S7, MIA-PaCa-2, PANC-I and T3M4) expressed the activin/inhibin βA subunit, whereas expression levels of the activin/inhibin βB and α subunits were undetectable. Furthermore, actRI, actRII and actRIIb were expressed in all cell lines and actRib mRNA was evident in ASPC-I, CAPAN-I, COLO357 and PANC-I cells. CAPAN-I and COLO-357 cells were growth-stimulated by activin A in the presence of 10{\%} serum, whereas the other cell lines were resistant to activin A. In contrast, in serum-free medium activin A inhibited the growth of CAPAN-I, COLO-357 and MIA-PaCa-2 cells. Pancreatic cancer samples markedly over-expressed the activin/inhibin βA subunit, whereas the βB subunit was only moderately increased in comparison to normal pancreatic samples. Pancreatic cancer tissues also markedly over-expressed actRI, actRib and actRII. By in situ hybridization, activin/inhibin βA, actRI, actRIb and actRII were strongly expressed in diffuse infiltrative and duct-like cancer cells. Both the ligand and its receptors were often co-expressed in these cells. Together, our findings suggest that activin A may participate in autocrine activation of pancreatic cancer cells in vivo.",
author = "J{\"o}rg Kleeff and Toshiyuki Ishiwata and Helmut Friess and B{\'u}chler, {Markus W.} and Murray Korc",
year = "1998",
doi = "10.1002/(SICI)1097-0215(19980911)77:6<860::AID-IJC11>3.0.CO;2-5",
language = "English (US)",
volume = "77",
pages = "860--868",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer

AU - Kleeff, Jörg

AU - Ishiwata, Toshiyuki

AU - Friess, Helmut

AU - Búchler, Markus W.

AU - Korc, Murray

PY - 1998

Y1 - 1998

N2 - Activins and inhibins belong to the transforming growth factor-β (TGF- β) superfamily of multifunctional cytokines that bind to transmembrane receptors with serine/threonine kinase activity. In this study, we characterized the levels of expression of 3 activin/inhibin subunits (βA, βB, α), and 2 type I and type II activin receptors (actRI/Ib, actRII/IIb) in pancreatic cancer cell lines and in human pancreatic tissues. In addition, we assessed the growth responsiveness to activin A in these cell lines. All 6 cell lines (ASPC-I, CAPAN-I, COLO-3S7, MIA-PaCa-2, PANC-I and T3M4) expressed the activin/inhibin βA subunit, whereas expression levels of the activin/inhibin βB and α subunits were undetectable. Furthermore, actRI, actRII and actRIIb were expressed in all cell lines and actRib mRNA was evident in ASPC-I, CAPAN-I, COLO357 and PANC-I cells. CAPAN-I and COLO-357 cells were growth-stimulated by activin A in the presence of 10% serum, whereas the other cell lines were resistant to activin A. In contrast, in serum-free medium activin A inhibited the growth of CAPAN-I, COLO-357 and MIA-PaCa-2 cells. Pancreatic cancer samples markedly over-expressed the activin/inhibin βA subunit, whereas the βB subunit was only moderately increased in comparison to normal pancreatic samples. Pancreatic cancer tissues also markedly over-expressed actRI, actRib and actRII. By in situ hybridization, activin/inhibin βA, actRI, actRIb and actRII were strongly expressed in diffuse infiltrative and duct-like cancer cells. Both the ligand and its receptors were often co-expressed in these cells. Together, our findings suggest that activin A may participate in autocrine activation of pancreatic cancer cells in vivo.

AB - Activins and inhibins belong to the transforming growth factor-β (TGF- β) superfamily of multifunctional cytokines that bind to transmembrane receptors with serine/threonine kinase activity. In this study, we characterized the levels of expression of 3 activin/inhibin subunits (βA, βB, α), and 2 type I and type II activin receptors (actRI/Ib, actRII/IIb) in pancreatic cancer cell lines and in human pancreatic tissues. In addition, we assessed the growth responsiveness to activin A in these cell lines. All 6 cell lines (ASPC-I, CAPAN-I, COLO-3S7, MIA-PaCa-2, PANC-I and T3M4) expressed the activin/inhibin βA subunit, whereas expression levels of the activin/inhibin βB and α subunits were undetectable. Furthermore, actRI, actRII and actRIIb were expressed in all cell lines and actRib mRNA was evident in ASPC-I, CAPAN-I, COLO357 and PANC-I cells. CAPAN-I and COLO-357 cells were growth-stimulated by activin A in the presence of 10% serum, whereas the other cell lines were resistant to activin A. In contrast, in serum-free medium activin A inhibited the growth of CAPAN-I, COLO-357 and MIA-PaCa-2 cells. Pancreatic cancer samples markedly over-expressed the activin/inhibin βA subunit, whereas the βB subunit was only moderately increased in comparison to normal pancreatic samples. Pancreatic cancer tissues also markedly over-expressed actRI, actRib and actRII. By in situ hybridization, activin/inhibin βA, actRI, actRIb and actRII were strongly expressed in diffuse infiltrative and duct-like cancer cells. Both the ligand and its receptors were often co-expressed in these cells. Together, our findings suggest that activin A may participate in autocrine activation of pancreatic cancer cells in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0031846251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031846251&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19980911)77:6<860::AID-IJC11>3.0.CO;2-5

DO - 10.1002/(SICI)1097-0215(19980911)77:6<860::AID-IJC11>3.0.CO;2-5

M3 - Article

C2 - 9714055

AN - SCOPUS:0031846251

VL - 77

SP - 860

EP - 868

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -